Devices that are approved through a process that does not require any clinical evidence for FDA authorization should not ...
With the FDA's new requirements for premarket submission and ongoing monitoring by medical device manufacturers in place, ...
Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...
The FDA has issued a recall for certain VasoView HemoPro Endoscopic Vessel Harvesting (EVH) Systems, adding these devices to ...
Update 03.16 PM EST: Adds comments from ResMed The U.S. Food and Drug Administration ... for its respiratory care devices, ...
Onward's Arc-Ex spinal cord stimulator earned the FDA's de novo classification and U.S. market authorization, according to a Dec. 19 news release.
In an update on Saturday, the FDA said that the risk classification for the recalls is Class I—a situation in which there is a reasonable probability that the use of or exposure to a violative ...